Evidence map›Paper›PMID 27573303›Full record

ReviewAngewandte Chemie (International ed. in English)2016

Evaluating New Chemistry to Drive Molecular Discovery: Fit for Purpose?

Daniel J Foley, Adam Nelson, Stephen P Marsden

Abstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Phenotyping Reveals Targets of a Pseudo-Natural-Product Autophagy Inhibitor.Angewandte Chemie (International ed. in English) · 2020
    Article
  9. Article
  10. Access to 3D Alicyclic Amine-Containing Fragments through Transannular C-H Arylation.Synlett : accounts and rapid communications in synthetic organic chemistry · 2019
    Article
  11. Automated and Accelerated Synthesis of Indole Derivatives on a Nano-Scale.Green chemistry : an international journal and green chemistry resource : GC · 2019
    Article
  12. Expanding the medicinal chemistry synthetic toolbox.Nature reviews. Drug discovery · 2018
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Evaluating New Chemistry to Drive Molecular Discovery: Fit for Purpose?Angewandte Chemie (International ed. in English) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daniel J FoleySchool of Chemistry, University of Leeds, Leeds, LS2 9JT, UK.ORCID 0000-0001-6221-3333
Adam NelsonSchool of Chemistry, University of Leeds, Leeds, LS2 9JT, UK. a.s.nelson@leeds.ac.uk.ORCID 0000-0003-3886-363X
Stephen P MarsdenSchool of Chemistry, University of Leeds, Leeds, LS2 9JT, UK. s.p.marsden@leeds.ac.uk.ORCID 0000-0002-2723-8954

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As our understanding of the impact of specific molecular properties on applications in discovery-based disciplines improves, the extent to which published synthetic methods meet (or do not meet) desirable criteria is ever clearer. Herein, we show how the application of simple (and in many cases freely available) computational tools can be used to develop a semiquantitative understanding of the potential of new methods to support molecular discovery. This analysis can, among other things, inform the design of improved substrate scoping studies; direct the prioritization of specific exemplar structures for synthesis; and substantiate claims of potential future applications for new methods.

Indexed as

computational toolslead-oriented synthesismolecular discoverymolecular propertiessynthetic chemistry

Identifiers

PMID27573303
PMCPMC5113762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.